Table 1.
Baseline characteristics of the study patients
| Variable | No restenosis (n=34) | Restenosis (n=12) |
| Age (years) | 62 (5) | 62 (4.5) |
| Male/female | 22/12 | 8/4 |
| Stable angina/unstable angina | 11/23 | 4/8 |
| Total cholesterol (mmol/l) | 5.85 (0.31) | 7.10 (0.35) |
| HDL cholesterol (mmol/l) | 1.32 (0.23) | 1.14 (0.21) |
| Non-HDL cholesterol (mmol/l)* | 4.53 (0.26) | 5.96 (0.41) |
| Triglycerides (mmol/l) | 1.63 (0.49) | 1.71 (0.59) |
| Patients with: | ||
| Previous myocardial infarction | 0 | 0 |
| Previous PTCA or CABG | 0 | 0 |
| Family history of IHD | 14 | 5 |
| Hypertension | 22 | 8 |
| Diabetes mellitus | 0 | 0 |
| Smokers | 0 | 0 |
| Treatment with: | ||
| Calcium channel blockers | 18 | 6 |
| Nitrates | 26 | 9 |
| Unfractionated sodium heparin | 34 | 12 |
| Aspirin | 34 | 12 |
| Ticlopidine | 34 | 12 |
| Statins | 11 | 4 |
| Fibrates | 0 | 0 |
| Culprit vessel : | ||
| RCA | 12 | 4 |
| LAD | 14 | 5 |
| LCx | 8 | 3 |
| Balloon inflations | 5 | 5 |
| Maximum pressure (atm) | 12.3 (3.0) | 12.2 (4.0) |
| Total inflation time (s) | 498 (126) | 487 (117) |
| Stent implantation | 0 | 0 |
Values are mean (SD) or n. *p < 0.05.
CABG, coronary artery bypass grafting; HDL, high density lipoprotein; IHD, ischaemic heart disease; LAD, left anterior descending coronary artery; LCx, left circumflex coronary artery; PTCA, percutaneous transluminal coronary angioplasty; RCA, right coronary artery.